49439 Effect of Ruxolitinib Cream on Patient-Reported Outcomes (PROs) in Children Aged 2–<12 Years With Atopic Dermatitis (AD): Results From a Randomized, Double-Blind, Vehicle-Controlled Phase 3 Study (TRuE-AD3).

Details

Language :

English

ISSN :

01909622

Volume :

91

Issue :

3

Database :

Supplemental Index

Journal :

Journal of the American Academy of Dermatology

Publication Type :

Academic Journal

Accession number :

179275728

Full Text :

https://doi.org/10.1016/j.jaad.2024.07.758